About STAQ Pharma
STAQ Pharma is a Healthcare company based in Denver (United States) founded in 2018. Drug discovery services are provided for pharmaceutical innovation. STAQ Pharma has raised $33.52 million across 6 funding rounds from investors including University Hospitals, Cincinnati Children’s and LCMC Health. The company has 30 employees. STAQ Pharma offers products and services including Sterile Medications and Oncology Portfolio. Its focus areas include Biopharma Outsourcing, CRO and Drug Discovery. Its legal entity is STAQ. Its competitors include Crown Bioscience, Alloy Therapeutics and NIH; 2 of its 3 listed competitors have raised funding.
Company details
STAQ Pharma was founded in 2018 and is headquartered in Denver, United States. Drug discovery services are offered within the pharmaceutical sector, supporting early-stage research and development processes. Operations encompass computational modeling, screening, and optimization techniques to aid in identifying potential therapeutic candidates. The focus remains on collaborative partnerships with biotech firms, ensuring efficient workflows from target identification to lead validation across the U.S. market.
- Headquarters Denver, United States
- Employees 30
- SectorsHealthcare
- Website staqpharma.com
- Social LinkedIn
- Legal Name Staq
- Total Equity Funding$33.52M (USD)
in 6 rounds
- Latest Funding Round$11.4M (USD), Series D
Sep 2024
- InvestorsUniversity Hospitals
& 6 more
- Employee Count30
Products & Services of STAQ Pharma
STAQ Pharma offers a comprehensive portfolio of products and services, including Sterile Medications and Oncology Portfolio.
Compounded sterile drugs for hospital use in shortages.
Medications addressing cancer drug shortages reliably.
Funding Insights of STAQ Pharma
STAQ Pharma has successfully raised a total of $33.52M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $11.4 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33.52M
- Total Rounds 6
- Last Round Series D — $11.4M
- Investors Count 7
All 6 funding rounds of STAQ Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $11.4M | Series D | – | – | – |
| Apr 2023 | $10.12M | Series C | – | – | – |
| Mar 2022 | Series C | – | Froedtert Health, UNC Health | ||
| Mar 2021 | $9M | Series B | – | – | – |
| Dec 2020 | Debt – Conventional | – | – | – | |
| Dec 2020 | $3M | Series A | – | – | – |
7 investors in total: 7 institutional.
Investors in STAQ Pharma
STAQ Pharma has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include University Hospitals, Cincinnati Children’s and LCMC Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startup Studio building companies in the US & Europe and Angel Network for Ohio based companies | rev1ventures.com | Columbus, United States | ||
A comprehensive health system delivering quality medical care. | 1980 | froedtert.com | Milwaukee, United States | |
Health systems | 1998 | unchealthcare.org | Chapel Hill, United States | |
Healthcare services are operated as a system in New Orleans. | 2009 | lcmchealth.org | New Orleans, United States | |
Multispecialty hospital care is delivered through a chain of facilities. | 1866 | uhhospitals.org | United States | |
Pediatric healthcare services are delivered through a hospital chain. | 1883 | cincinnatichildrens.org | United States | |
Pediatric care is delivered through a nationwide hospital network. | 1892 | nationwidechildrens.org | United States |
Investor details for STAQ Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of STAQ Pharma
27 people are tracked at STAQ Pharma (12 in leadership, 6 in board & advisors, 9 in team); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
Lou Thao | Vice President Operations | Leadership |
Jeff Hval | COO, Chief Pharmacist & Board Member | Leadership |
Mark Spiecker | President & Board Member | Leadership |
Patrick Griffith | Director of Manufacturing Science and Technology | Leadership |
Joe Bagan | CEO & Board Member | Leadership |
Jonathan Hungerford | Director of IT | Leadership |
Bryce Gode | Director Of Quality | Leadership |
Evan Brunick | Director Of Finance | Leadership |
David Colson, CPA | Chief Financial Officer | Leadership |
Paul Lisska Jr | Director - Manufacturing Science And Technology | Leadership |
Jon Hicks, Pharm.D., BCSCP | Director of Pharmacy - Columbus OH | Leadership |
Rocco J Rotello | Director of Laboratory Operations | Leadership |
Steven Summer | Board Member | Board & advisors |
Jerrod Milton | Board Member | Board & advisors |
Dan Seff | Board Member | Board & advisors |
Chet Kaczor | Board Member | Board & advisors |
Donna Lynne | Board Member | Board & advisors |
Steve Davis | Board Member | Board & advisors |
Johnathan Miller Jr | Information Security Manager | Team |
Tyler Bishop | Senior Engineer | Team |
7 more people are available in the full profile.
Complete people profiles for STAQ Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of STAQ Pharma
3 dated milestones of STAQ Pharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded STAQ Pharma is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $11.4M.
Competitors of STAQ Pharma
STAQ Pharma has 3 listed competitors in our database, 2 of them funded. They include Crown Bioscience, Alloy Therapeutics and NIH.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| crownbio.com | 2006 | Santa Clara, United States | $85.87M | 18 | Cancer and CVMD drugs are developed using PDX models. | |
| alloytx.com | 2017 | Lexington, United States | $157M | Drug discovery services are provided for therapeutic development. | ||
| nih.gov | 1887 | United States | Drug discovery services are provided to the biopharma sector. |
Detailed competitors of STAQ Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of STAQ Pharma
The website of STAQ Pharma (staqpharma.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 6.2% vs previous month
Websites whose visitors overlap most with STAQ Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ohiolifesciences.org | ohiolifesciences.org | 100% | #4,658,196 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as STAQ Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Staq Pharma
Complete news archive for STAQ Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STAQ Pharma
STAQ Pharma was founded in 2018 and raised its 1st funding round 2 years after it was founded.
STAQ Pharma is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
STAQ Pharma is a funded company, having raised a total of $33.52M across 6 funding rounds to date.
STAQ Pharma has 30 employees.
STAQ Pharma was founded in 2018 and is headquartered in Denver, United States. Drug discovery services are offered within the pharmaceutical sector, supporting early-stage research and development processes. Operations encompass computational modeling, screening, and optimization techniques to aid in identifying potential therapeutic candidates. The focus remains on collaborative partnerships with biotech firms, ensuring efficient workflows from target identification to lead validation across the U.S. market.
STAQ Pharma's top competitors include Crown Bioscience, NIH and Alloy Therapeutics.
STAQ Pharma offers Sterile Medications and Oncology Portfolio.
STAQ Pharma has 7 investors. Key investors include University Hospitals, Cincinnati Children’s, LCMC Health, Nationwide Children's Hospital, and UNC Health.
STAQ Pharma operates through Staq.